On the basis of our long-term experience in patient-specific individual imports and the supply of
emergency medications not available in a uniform manner, Komtur developed a concept for its industry customers that can be used to make innovative products available even before they receive a national marketing approval.

• New products are made available to therapists, key opinion leaders and, of course,
  patients before their national marketing approval.
• First successful treatments and the experience gained in product administration significantly improve the baseline situation for the post-approval marketing of the drug.
• The worldwide infrastructure Komtur provides opens up a wide range of pre-marketing opportunities, reaching from individual national solutions for time-critical drugs to Europe
  or worldwide launches, depending on customer needs, strategic alignment
  or geographical spread of patients.
• Prices can be set pro-actively since all pre-marketing activities are managed centrally,
  and controlled fully, by Komtur. Any distortions resulting from prior parallel trade
  or conflicting prices following marketing approval are thus excluded.
• A comprehensive reporting system managed by Komtur provides a clear picture
  of product flows and product appreciation.

For a successful pre-marketing concept, the drug manufacturer must have obtained a marketing approval in at least one country (usually the country in which the drug was developed).
In addition, applicable laws and regulations must permit the lawful import and sale to the patient in the target markets.

Home / Our Services / Pre-Marketing

© 2009 Komtur Pharmaceuticals